MAP2K7 and lymphoma: According to the cell line Encyclopedia (CCLE), MAP2K7 is highly expressed in multiple myeloma, chronic myeloid leukemia, lymphomas, B-cell acute lymphoblastic leukemia (B-ALL), and T-cell acute lymphoblastic leukemia (T-ALL).